PBI-0451

Pomotrelvir · Pardes Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PBI-0451, covering 2024-12-11 to 2024-12-11. Get the full timeline:

Most recent: Clinical Trial Update: PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19 [Phase 2]